CareDx (CDNA) legal chief logs RSU awards, tax withholdings and 4,441-share sale
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CareDx, Inc. Secretary and General Counsel Jeffrey Adam Novack reported multiple equity transactions in company common stock. He was granted 33,000 restricted stock units that begin vesting on April 6, 2027 over three years, subject to continued employment, and 4,342 shares from a performance RSU award earned after performance criteria were certified on February 2, 2026. To cover tax withholding on PRSU and RSU vesting, 2,492 and 2,970 shares, respectively, were withheld by CareDx. On February 3, 2026, 4,441 shares were sold at $20.5553 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, Novack directly held 125,364 shares of CareDx common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,441 shares ($91,286)
Net Sell
5 txns
Insider
Novack Jeffrey Adam
Role
Secretary and General Counsel
Sold
4,441 shs ($91K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,441 | $20.5553 | $91K |
| Grant/Award | Common Stock | 33,000 | $0.00 | -- |
| Grant/Award | Common Stock | 4,342 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,492 | $20.42 | $51K |
| Tax Withholding | Common Stock | 2,970 | $20.42 | $61K |
Holdings After Transaction:
Common Stock — 125,364 shares (Direct)
Footnotes (1)
- The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the RSUs will be vested on the third anniversary of April 6, 2027, subject to the Reporting Person's continuous employment on each applicable vesting date. The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human Capital Committee of the Issuer's Board of Directors on February 2, 2026. These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs. These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of RSUs. The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025.
FAQ
What insider transactions did CareDx (CDNA) report for Jeffrey Adam Novack?
CareDx reported that Secretary and General Counsel Jeffrey Adam Novack received 33,000 RSUs, 4,342 performance-based shares, had 5,462 shares withheld for taxes, and sold 4,441 shares at $20.5553 each. After these transactions, he directly owned 125,364 shares of common stock.
How many CareDx (CDNA) restricted stock units did Jeffrey Novack receive?
Jeffrey Novack received 33,000 restricted stock units in CareDx common stock. One-third of these RSUs will vest on April 6, 2027, with the remaining two-thirds vesting in eight equal quarterly installments, subject to his continuous employment on each vesting date.
What is the vesting schedule for Jeffrey Novack’s CareDx (CDNA) RSU grant?
The 33,000 RSUs granted to Jeffrey Novack vest over three years. One-third vests on April 6, 2027, and the remaining two-thirds vest in equal quarterly installments over the next eight quarters, assuming he remains continuously employed on each vesting date.